@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

nalt:10252
  skos:prefLabel "hipercolesterolemia"@es, "hypercholesterolemia"@en ;
  a <https://lod.nal.usda.gov/naltv#Topic>, skos:Concept ;
  skos:related nalt:266075 .

nalt:10249
  skos:prefLabel "agentes antilipémicos"@es, "antilipemic agents"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:narrower nalt:266075 .

<https://lod.nal.usda.gov/naltv#Chemical>
  rdfs:label "Chemical"@en ;
  a owl:Class .

nalt:10403
  skos:prefLabel "efecto lipémico"@es, "lipemic effect"@en ;
  a <https://lod.nal.usda.gov/naltv#Topic>, skos:Concept ;
  skos:related nalt:266075 .

nalt:266075_def
  rdf:value "Agente antilipémico que reduce los niveles de colesterol y triglicéridos en la sangre."@es, "An antilipemic agent which reduces both cholesterol and triglycerides in the blood."@en ;
  dc:source "Medical Subject Headings 2016" ;
  a <https://lod.nal.usda.gov/naltv#Definition> .

<https://lod.nal.usda.gov/nalt>
  rdfs:label "NALT Full"@en ;
  a skos:ConceptScheme .

nalt:266075
  skos:broader nalt:10249 ;
  skos:definition nalt:266075_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:related nalt:10252, nalt:10403, nalt:18135 ;
  dc:modified "2016-11-14"^^xsd:date ;
  skos:prefLabel "fenofibrate"@en, "fenofibrato"@es ;
  dc:created "2015-12-30"^^xsd:date ;
  a skos:Concept, <https://lod.nal.usda.gov/naltv#Chemical> ;
  ns0:marc001 "76768" .

nalt:18135
  skos:prefLabel "colesterol"@es, "cholesterol"@en ;
  a ns0:Chemical, skos:Concept ;
  skos:related nalt:266075 .